ACLY and acute myeloid leukemia: This is achieved through the upregulation of key enzymes in FA anabolic processes, such as ATP-citrate-lyase (ACLY) and stearoyl CoA desaturase 1 (SCD1), although clinical evidence supporting a favourable effect of their inhibition is still lacking in AML treatment [152,153].